LIU, Jianghai
$135,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2013-2014
Canada
Antibodies Targeting the ErbB2/ErbB3/IGF-1R Complex as Therapeutics for ErbB2 Positive Breast Cancer